'Ng ml' diaporamas de présentation

Part I MCQs (One Best Type)

Pakistan Society Of Chemical Pathologists Distance Learning Programme In Chemical Pathology (DLP-2) Lesson No 16 Metabolic Bone Disease By Dr Lena Jafri MBBS , FCPS Consultant Chemical Pathologist Aga Khan University Hospital. Part I MCQs (One Best Type).

2.43k views • 95 slides

Preclinical development of a novel sildenafil analogue

Preclinical development of a novel sildenafil analogue. www.gdenucci.com Email - denucci@gdenucci.com. Regular Drug Development Process. (Steps from Test Tube to New Drug Application Review).

1.11k views • 91 slides

764 views • 65 slides

EMQs

1.25k views • 58 slides

??? D ?????? Rickets of Vitamin D Deficiency

??? D ?????? Rickets of Vitamin D Deficiency. ??????????????? ????????? ???. ???. ??? D ??????????????? D ??????????????????????????????????????????????????????. ???? . ??? ?????????????????????????? ??? ?????????? ????? ???????????????. ??? D ????????. ??? D ??????????????????

772 views • 54 slides

Stefano Savonitto, Claudio Cavallini

614 views • 47 slides

Ospedale Amedeo di Savoia

648 views • 42 slides

STAMPEDE trial (MRC PR08): Arm J overview

1.02k views • 39 slides

What common features are shared among various forms of shock?

What common features are shared among various forms of shock?. Anthony F. Suffredini M.D. Critical Care Medicine Department National Institutes of Health Bethesda, MD, USA. Reduced Tissue Perfusion. Common Shock Syndromes. Hypovolemic Shock Severe hemorrhage Extensive trauma Burns

666 views • 31 slides

633 views • 26 slides

Cyclosporine

Cyclosporine. REFERENCE: APPLIED CLINICAL PHARMACOKINETICS Slideshow by: lecturer HADEEL DELMAN. THERAPEUTIC AND TOXIC CONCENTRATIONS. The therapeutic range of cyclosporine depend on: the type of assay used to measure cyclosporine concentration

2.36k views • 24 slides

MORPHINE: New Findings of an Old Drug By Amnuay Thithapandha, Ph.D. Professor, Office of Academic Affairs

MORPHINE: New Findings of an Old Drug By Amnuay Thithapandha, Ph.D. Professor, Office of Academic Affairs Faculty of Medicine Ramathibodi Hospital Mahidol University. Among the remedies which it has pleased Almighty God to give to man

618 views • 23 slides

Hideaki Higashino , Atsuko Niwa, Masaki Tabuchi, Kana Ooshima, and Hiroshi Sakaue

Long-term Voluntary Exercise Decreased the Incidence of Apoplexy and Elongated the Lifespan through Activation of eNOS and Inhibition of Inflammatory Signaling Pathway in Stroke-Prone SHR. Hideaki Higashino , Atsuko Niwa, Masaki Tabuchi, Kana Ooshima, and Hiroshi Sakaue

454 views • 22 slides

Approach to a man with Lower Urinary Tract Symptoms

Approach to a man with Lower Urinary Tract Symptoms. Dr. Yeung Fun Na, Fannie. Obstructive Hesitancy Weak stream Intermittency Terminal dribbling Incomplete emptying Straining Prolonged micturiction Overflow incontinence. Irritative Urgency Urge incontinence Frequency Nocturia

623 views • 22 slides

311 views • 20 slides

Yale SPORE in Skin Cancer

Yale SPORE in Skin Cancer. Directors: Ruth Halaban, PhD Mario Sznol, MD Robert Tigelaar, MD. Funded by: National Institutes of Health The Roslyn and Jeremy Meyer funds Yale Dermatology Department. Milstein Meyer Center for Melanoma Research. Jeremy Meyer and Roslyn Milstein Meyer

340 views • 16 slides

Supplemental figures.

Supplemental figures.

181 views • 11 slides

Antibody concentration ( ng /ml)

A. Absorbance (OD). Antibody concentration ( ng /ml). B. C.

121 views • 1 slides

1E+4

hAAT (ng/ml). 1E+7. sAg-25. AAV-8. 1E+6. AAV-1. 1E+5. hAAT-19. 1E+4. 0. 20. 40. 60. 80. 100. 120. 140. 160. 180. Days post injection.

169 views • 1 slides

No stim.

MEEC. A. TGF- b (0.25 ng/ml). B. TGF- b (5 ng/ml). BAEC. - TGF- b. No stim. caALK1. caALK5. Smad7. Marker. H 2 O. LacZ. +TGF- b. 400 MOI F-Smad7. 1000 MOI LacZ. 1000 MOI F-Smad7. 400 MOI LacZ. 0.25. 0.25. PS1. 0.1. 0.5. 2.5. 0.1. 0.5. 2.5. 0.5. 1.5. 0.5. 1.5.

174 views • 1 slides